It’s been another low volume period, the type of week that can be frustrating but ultimately rewarding for the buyers. Apparently the good folk at Peloton can’t believe they’re getting shares at these prices, particularly as IHL is getting close to such a significant period of news flow.
The same contact mentioned to me today that GW Pharmaceuticals has a similar strategy to the one IHL is targeting. They have IP in a cannabis drug called Epidiolex. Apparently GW Pharma now has a $3 billion market cap.
- Forums
- ASX - By Stock
- IHL
- Share your ideas and thoughts.
Share your ideas and thoughts., page-186
-
-
- There are more pages in this discussion • 505 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online